chr12-52516824-C-T
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 6P and 1B. PM1PP3_StrongBS1_Supporting
The NM_000424.4(KRT5):c.1252G>A(p.Glu418Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000192 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).
Frequency
 Genomes: 𝑓 0.000013   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000020   (  0   hom.  ) 
Consequence
 KRT5
NM_000424.4 missense
NM_000424.4 missense
Scores
 9
 9
 1
Clinical Significance
Conservation
 PhyloP100:  6.05  
Publications
10 publications found 
Genes affected
 KRT5  (HGNC:6442):  (keratin 5) The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Mutations in these genes have been associated with a complex of diseases termed epidermolysis bullosa simplex. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. [provided by RefSeq, Jul 2008] 
KRT5 Gene-Disease associations (from GenCC):
- Dowling-Degos diseaseInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
 - epidermolysis bullosa simplex 1A, generalized severeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Ambry Genetics
 - epidermolysis bullosa simplex 2F, with mottled pigmentationInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia, G2P
 - Dowling-Degos disease 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
 - epidermolysis bullosa simplex 1B, generalized intermediateInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
 - epidermolysis bullosa simplex 1C, localizedInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
 - epidermolysis bullosa simplex 2B, generalized intermediateInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessiveInheritance: AR Classification: STRONG Submitted by: PanelApp Australia
 - epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessiveInheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
 - epidermolysis bullosa simplex 2E, with migratory circinate erythemaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
PM1
In a region_of_interest Coil 2 (size 138)  in uniprot entity K2C5_HUMAN there are 20 pathogenic changes around while only 1 benign (95%) in NM_000424.4
PP3
MetaRNN computational evidence supports a deleterious effect, 0.987
BS1
Variant frequency is greater than expected in population eas. GnomAdExome4 allele frequency = 0.0000198 (29/1461880) while in subpopulation EAS AF = 0.000453 (18/39700). AF 95% confidence interval is 0.000293. There are 0 homozygotes in GnomAdExome4. There are 18 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.  Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000131  AC: 2AN: 152168Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2
AN: 
152168
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000119  AC: 3AN: 251286 AF XY:  0.00000736   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
3
AN: 
251286
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000198  AC: 29AN: 1461880Hom.:  0  Cov.: 31 AF XY:  0.0000248  AC XY: 18AN XY: 727244 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
29
AN: 
1461880
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
18
AN XY: 
727244
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33480
American (AMR) 
 AF: 
AC: 
1
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
18
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53412
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
5
AN: 
1112008
Other (OTH) 
 AF: 
AC: 
4
AN: 
60394
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.480 
Heterozygous variant carriers
 0 
 2 
 4 
 5 
 7 
 9 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0000131  AC: 2AN: 152168Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74338 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2
AN: 
152168
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1
AN XY: 
74338
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
41438
American (AMR) 
 AF: 
AC: 
0
AN: 
15272
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5186
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10618
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
68042
Other (OTH) 
 AF: 
AC: 
0
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.625 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
TwinsUK 
 AF: 
AC: 
1
ALSPAC 
 AF: 
AC: 
0
ExAC 
 AF: 
AC: 
1
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: risk factor 
Submissions summary: Other:2 
Revision: no assertion criteria provided
LINK: link 
Submissions by phenotype
not provided    Other:1 
-
Epithelial Biology; Institute of Medical Biology, Singapore
Significance:not provided
Review Status:no classification provided
Collection Method:literature only
- -
Epidermolysis bullosa simplex 2C, localized, modifier of    Other:1 
Jun 28, 2002
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Pathogenic 
 DEOGEN2 
 Pathogenic 
D 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Uncertain 
D 
 M_CAP 
 Uncertain 
D 
 MetaRNN 
 Pathogenic 
D 
 MetaSVM 
 Uncertain 
D 
 MutationAssessor 
 Pathogenic 
M 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Uncertain 
D 
 REVEL 
 Pathogenic 
 Sift 
 Pathogenic 
D 
 Sift4G 
 Uncertain 
D 
 Polyphen 
D 
 Vest4 
 MutPred 
Gain of MoRF binding (P = 0.0028);
 MVP 
 MPC 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.